CoChat

Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care

Clancy, Cornelius J., Nguyen, M. Hong · 2013 · Clinical Infectious Diseases

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Blood cultures are limited for diagnosing invasive candidiasis by poor sensitivity and slow turn-around time. New diagnostics are needed to complement cultures, in particular to identify the "missing 50%" of patients who are blood culture-negative. Mannan/anti-mannan immunoglobulin G, β-D-glucan (BDG) and polymerase chain reaction (PCR) assays can diagnose candidemia before blood cultures and show promising sensitivity/specificity, but they are not widely investigated in blood culture-negative, deep-seated candidiasis. In a recent study, BDG and PCR were superior to blood cultures in deep-seated candidiasis, suggesting they may identify currently undiagnosed patients and expand our understanding of disease spectrum. Positive predictive values of nonculture tests are limited by the low prevalence of invasive candidiasis, which mandates that results be interpreted judiciously. When used as biomarkers that assess a patient's risk of having invasive candidiasis, tests will facilitate preemptive antifungal strategies. Because negative predictive values are excellent, tests will also be useful for ruling out invasive candidiasis and discontinuing unnecessary antifungal therapy.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/cit006

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Research works printed but not linked: 1

  1. Nguyen MH Clancy CJ . Washington, DC: American Society for Microbiology; 2012. Intra-abdominal candidiasis (IAC) Is under-recognized, but is the most common yype of invasive candidiasis (IC) and results in poor outcomes [abstract M1685]; p. 164. Program and abstracts of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco.

Cited by

See all 688

Metadata

Authors
Clancy, C. J., & Nguyen, M. H.
Affiliations
University of Pittsburgh (US)
Corresponding author
Clancy, Cornelius J.
Venue
Clinical Infectious Diseases
Published
2013-01-11
Volume
56
Issue
9
Pages
1284-1292
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2113002556
Cited by
688
References
39
Citations by year
2026: 36 · 2025: 56 · 2024: 55 · 2023: 60 · 2022: 59 · 2021: 68 · 2020: 56 · 2019: 66 · 2018: 60 · 2017: 54 · 2016: 52 · 2015: 32 · 2014: 26 · 2013: 8
FWCI
5.08
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
invasive candidiasis, beta-D-glucan assay, sensitivity and specificity, positive predictive value, negative predictive value, antifungal therapy, disease spectrum, biomarkers
MeSH terms
DNA, Fungal, Patient Care, Humans, Predictive Value of Tests, Sensitivity and Specificity, Biomarkers, Clinical Laboratory Techniques, beta-Glucans, Candidiasis, Invasive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.